Ariad Pharmaceuticals Leading Biotechs Higher

Published 09/15/2016, 12:56 AM
Updated 05/14/2017, 06:45 AM
ARIA
-
META
-

I run a bullscan multiple times per day. It looks for stocks that can be higher flyers due to a combination of momentum indicators and short interest for fuel. This bull scan gets posted daily on the Dragonfly Capital Facebook (NASDAQ:FB) page at the end of each day. For the past two months this scan has been loaded up with Technology and Services sector names. Some days more that others, but those two sectors have mad up the majority of the stocks on the scan.

Today that changed. As I write this the broad market is moving sideways and the make up of the bull scan has shifted. Technology and Services sectors still make up half of the list. But the other half is now made up of entirely the Healthcare sector. There are 13 names in all and 6 in Healthcare. But diving even deeper, 5 of those 6 are Biotech stocks, and one in particular, ARIAD Pharmaceuticals Inc (NASDAQ:ARIA) is breaking out.

ARIA Daily Chart

The chart above shows the stock started higher out of a wedge in February with a slow trend higher to a peak in early June. A short pullback to a higher low in late June then saw a steep move up in July yo a plateau in early August. It sat there, consolidating for 6 weeks after that. Wednesday it broke that consolidation range to the upside. The break gives a target to 13.60. Momentum is strong with the RSI in the bullish zone and rising while the MACD is about to cross up. And the Bollinger Bands are also opening to the upside.

Leadership may be changing and it would be none too soon for the Biotech stocks. Keep your eyes on this space.

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.

Original post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.